您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 1-4.doi: 10.6040/j.issn.1671-7554.0.2021.0247

• 骨质疏松症新进展专题 •    下一篇

原发性骨质疏松症诊治思考

邢小平   

  1. 中国医学科学院 北京协和医学院 北京协和医院内分泌科 国家卫生健康委员会内分泌重点实验室, 北京 100730
  • 发布日期:2021-06-10
  • 通讯作者: 邢小平. E-mail:xiaopingxing@126.com

Diagnosis and management of primary osteoporosis

XING Xiaoping   

  1. Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science &
    Peking Union Medical College, Beijing 100730, China
  • Published:2021-06-10

RichHTML

99

PDF (PC)

374

摘要： 我国即将快速进入老龄社会,骨质疏松骨折严重威胁老年人生命及生活质量,给家庭和社会造成严重负担。对骨质疏松症认知水平的提高及对其诊治过程细节的了解和掌握将有助于更精准的完成诊疗,从而更有效地降低骨质疏松骨折风险。

关键词: 骨质疏松症, 诊断, 治疗

Abstract: With the emerging era of aging in China, osteoporotic fracture has adversely affected the health and quality of life of the elderly population, bringing huge burden to families and society. Raising awareness of osteoporosis, and understanding the diagnosis and management will greatly help doctors achieve better disease control and reduce the risk of osteoporotic fracture.

Key words: Osteoporosis, Diagnosis, Management

中图分类号: 

  • R681
[1] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 25(3): 413-443. Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the diagnosis and treatment of primary osteoporosis(2017)[J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2017, 25(3): 413-443.
[2] Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 Update [J]. Endocr Pract, 2020, 26(Suppl 1): 1-46.
[3] Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J]. Osteoporos Int, 2013, 24(1): 23-57.
[4] Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures [J]. Osteoporos Int, 2020, 31(1): 1-12.
[5] 夏维波. 骨质疏松症高骨折风险患者的识别与防治策略[J]. 中华骨质疏松和骨矿盐疾病杂志, 2020, 13(6): 493-498. XIA Weibo. Identification and management strategies for osteoporosis patients with high fracture risk [J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2020, 13(6): 493-498.
[6] Cui L, He T, Jiang Y, et al. Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data [J]. Osteoporos Int, 2020, 31(2): 307-316.
[7] Barrionuevo P, Kapoor E, Asi N, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis [J]. J Clin Endocrinol Metab, 2019, 104(5): 1623-1630.
[8] Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline [J]. J Clin Endocrinol Metab, 2019, 104(5): 1595-1622.
[9] Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-Term Extension(FLEX): a randomized trial [J]. JAMA, 2006, 296(24): 2927-2938.
[10] Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: A randomized extension to the horizon-pivotal fracture trial(Pft)[J]. J Bone Miner Res, 2012, 27(2): 243-254.
[11] Anastasilakis AD, Polyzos SA, Yavropoulou MP, et al. Combination and sequential treatment in women with postmenopausal osteoporosis [J]. Expert Opin Pharmacother, 2020, 21(4): 477-490.
[12] Leder BZ, Tsai JN, Uihlein AV, et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis(the DATA-Switch study): Extension of a randomised controlled trial [J]. Lancet, 2015, 386(9999): 1147-1155.
[13] Geusens P, Marin F, Kendler DL, et al. Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial [J]. J Bone Miner Res, 2018, 33(5): 783-794.
[14] Langdahl B. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches [J]. Bone, 2020, 139: 115516. doi:10.1016/j.bone.2020.115516.
[1] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2] 巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[3] 王欣，邢春燕，杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94.
[4] 徐平 于国放 李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64.
[5] 王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.
[6] 韩靖,贾春玲. 肺癌患者胸外手术前治疗牙周基础疾病对预防术后肺炎发生的效果评价[J]. 山东大学学报 (医学版), 2022, 60(9): 113-118.
[7] 孙文雄,吴日超,郑贤静,李丽, 张友忠. 宫颈血管周上皮样细胞肿瘤1例[J]. 山东大学学报 (医学版), 2022, 60(9): 125-128.
[8] 吴瑞芳,李长忠. 女性生育力保护的现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 1-7.
[9] 陈诗鸿,姜冬青,庄向华,李晓博,潘喆,孙爱丽,娄能俊,王殿辉,杜娇娇,宋玉文. 以骨痛为首发表现的原发性胆汁性胆管炎1例[J]. 山东大学学报 (医学版), 2022, 60(8): 98-102.
[10] 王文静,刘博策,毕见海,霍然. 超声引导下平阳霉素联合聚桂醇硬化治疗94例囊性淋巴管畸形的疗效[J]. 山东大学学报 (医学版), 2022, 60(8): 72-78.
[11] 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25.
[12] 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[13] 王福立,孙银萍,秦杰,荣建胜. DC-CIK细胞联合EGFR-TKI治疗35例老年晚期EGFR突变肺癌的效果[J]. 山东大学学报 (医学版), 2022, 60(7): 110-117.
[14] 查菁,郭婧,左秀丽. 少见类型肠梗阻病因病例报告1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 130-132.
[15] 宋敏,周玉侠,高璐,刘娜,王菊,古晋,张艳萍. 1例6 q三体嵌合胎儿的产前诊断[J]. 山东大学学报 (医学版), 2022, 60(5): 109-113.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[2] 高静,陈雯,张同霞,王小花,戴廷军,姚红,赵秀鹤,迟兆富,单培彦 . 颞叶癫痫大鼠海马线粒体细胞色素氧化酶亚基Ⅲ和Ⅳ表达的变化[J]. 山东大学学报(医学版), 2007, 45(8): 817 -820 .
[3] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[4] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[5] . 干细胞标记物LGR5在结直肠癌发生发展中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(8): 85 -88 .
[6] 王海峰,史本康,张克勤,李永智,朱耀丰,王海新. B超检测的精索静脉直径及返流与术后精液质量的关系[J]. 山东大学学报(医学版), 2007, 45(7): 751 -752 .
[7] 张元凯，刘培来，李德强，李明. 枢椎椎板螺钉联合寰椎侧块螺钉固定技术在复杂寰枢椎脱位中的应用[J]. 山东大学学报(医学版), 2010, 48(11): 98 .
[8] 于渊1,李岩1,荣风年2,梁婧1,刘晓琳1,王福立1. 自体CIK细胞治疗对卵巢癌调节性T细胞的影响[J]. 山东大学学报(医学版), 2010, 48(5): 101 -104 .
[9] 韩露1，王彬2，牟晓梅2，巩会平3，闫会敏1，王志浩1，张运1，张薇1，钟明1. 代谢综合征患者心脏损害与脂肪因子变化的临床研究[J]. 山东大学学报(医学版), 2011, 49(9): 63 .
[10] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发